Dr. Agarwal’s Health Care Limited Allots Over 1.5 Crore Equity Shares After Merger with Eye Hospital Arm
Total paid-up equity capital rises to ₹33.22 crore as new shares to be listed on BSE and NSE following approved share exchange ratio
Dr. Agarwal’s Health Care Limited has allotted 1,51,90,373 equity shares to shareholders of Dr. Agarwal’s Eye Hospital Limited as part of a merger scheme, increasing its paid-up equity capital to ₹33.22 crore. The new shares rank equally with existing shares and listing approvals are underway at BSE and NSE.
Dr. Agarwal’s Health Care Limited
Acquisition / Amalgamation / Merger / Demerger
Dr. Agarwal’s Health Care Limited has issued 1,51,90,373 fully paid equity shares to shareholders of Dr. Agarwal’s Eye Hospital Limited pursuant to their merger, raising its paid-up equity capital to ₹33,22,89,484 comprised of 33,22,89,484 shares of ₹1 each.
The share allotment was approved by the board through a circular resolution on November 19, 2026, and follows a share exchange ratio under the amalgamation scheme of 23 shares of Dr. Agarwal’s Health Care Limited for every 2 shares held in Dr. Agarwal’s Eye Hospital Limited.
The equity shares allotted will rank pari passu with the existing shares of Dr. Agarwal’s Health Care Limited.
Prior to the merger, 35,11,925 shares (₹10 face value each) held by Dr. Agarwal’s Health Care Limited in Dr. Agarwal’s Eye Hospital Limited were cancelled and extinguished.
The company will seek listing and trading approval for the new shares from BSE and NSE to enable market trading.
The record date for entitlement was November 18, 2026, and details of the allotment have been updated on the company’s website.
Highlights
- 1,51,90,373 equity shares of ₹1 each allotted under the amalgamation scheme.
- Share exchange ratio: 23 shares of the health care company for every 2 shares of the eye hospital company.
- Paid-up equity capital increased from ₹31.71 crore to ₹33.22 crore.
- Cancellation of 35,11,925 ₹10 equity shares previously held in the eye hospital.
- Listing approvals pending for new shares on BSE and NSE to enable trading.
Key Data Snapshot
What happened
- Dr. Agarwal’s Health Care Limited allotted 1,51,90,373 fully paid equity shares to eligible shareholders of Dr. Agarwal’s Eye Hospital Limited after merger.
- The allotment aligns with the approved share exchange ratio under the Scheme of Amalgamation.
- The company's paid-up equity share capital increased as a result of the allotment.
Key details
- New shares carry a face value of ₹1 and rank equally with existing shares.
- Prior holdings of 35,11,925 shares (₹10 face value) in the Transferor Company by Dr. Agarwal’s Health Care Limited were cancelled.
- Listing and trading approvals for the allotted shares will be sought from BSE and NSE.
- Record date for allotment was November 18, 2026, with board approval on November 19, 2026.
Highlights
- 1,51,90,373 equity shares of ₹1 each allotted under the amalgamation scheme.
- Share exchange ratio: 23 shares of the health care company for every 2 shares of the eye hospital company.
- Paid-up equity capital increased from ₹31.71 crore to ₹33.22 crore.
- Cancellation of 35,11,925 ₹10 equity shares previously held in the eye hospital.
- Listing approvals pending for new shares on BSE and NSE to enable trading.
Disclosures
- Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Acquisition / Amalgamation / Merger / Demerger
View allLatest corporate announcements and market updates in Acquisition / Amalgamation / Merger / Demerger.
FIH Mauritius Investments Ltd Acquires 3.24% Additional Stake in IIFL Capital Services, Becoming Promoter
FIH Mauritius Investments Ltd acquired 1,20,58,525 equity shares representing 3.24% stake in IIFL Capital Services Limited through an open offer completed on November 18, 2026. This acquisition boosted their total shareholding to 41.28%, making them the promoter of IIFL Capital Services as of November 19, 2026.
Read Full StoryICICI Prudential AMC Secures SEBI Approval to Acquire PMS Business from ICICI Securities
ICICI Prudential Asset Management Company Limited announced receipt of SEBI's approval to acquire the Portfolio Management Services business from ICICI Securities Limited, allowing the progression of the slump sale transaction agreed earlier in 2026.
Read Full Story3B BlackBio Dx's Coris BioConcept Acquires Bilex SRL to Own Manufacturing Facility, Generating €140,000 Annual Savings
Coris BioConcept SRL, a subsidiary of 3B BlackBio Dx Limited, acquired 100% ownership of Bilex SRL, the entity that owns the land and building of Coris's manufacturing plant and office in Gembloux, Belgium, for €274,817. This acquisition, completed on November 18, 2026, transitions Coris from tenant to owner, eliminating rental payments and generating annual savings.
Read Full Story